Skip to content

ARTHUR PHARMA

Active Private limited companyfounded 2025active for 1 yearKleinenbergstraat 73, 1932 ZaventemKBO/BCE: BE 1020.149.493

Lifetime

1 annual account with figures
peak of €78,727 in 2025
€78,727 
peak of €58,718 in 2025
€58,718 
peak of €61,718 in 2025
€61,718 
€32,109 
Board1 name since 2025
1 director
Documentsfilings and deeds
29-07-20262 days before the deadline
2025micro format
Incorporation 21-021 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €380,000 estimated

The micro format states no turnover.

Position in the sector

€58,718

Higher net result than 90% of companies in retail trade. The sector median is €4,724, over 25,399 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,280 companies had the same profile as ARTHUR PHARMA has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.8%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,280 companies, not a prediction for ARTHUR PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 19-02-2025
  • 100 sharesdeed of 21-02-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1020149493
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 21-02-2025 · Gazette deed
First establishment Kleinenbergstraat 73, Zaventem
All 4 events

Comparable companies

same main activity, similar in size and age
Company
ARTHUR PHARMA Zaventem €93,827 €78,727 65.8% -
CALIS CHARLOTTE Menen €88,030 €77,490 70.0% -
FARMARIE Destelbergen €94,659 €70,507 75.3% -
MENCINA Antwerp €99,620 €88,196 67.6% -
KLIPPER-T Kapelle-op-den-Bos €75,573 €62,105 65.6% -
Farma & Fit Rotselaar €71,427 €60,338 62.9% -
JOERI MAX Peer €92,467 €66,416 70.5% -

These companies have the same main activity as ARTHUR PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €71,400 and €99,600, founded in 2024.

Official details

Source: KBO
Status
Active since 19-02-2025Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.370.604.0811932 Zaventem, since 19-02-2025
Financial year end
31 December
Peppol
Reachable since 09-12-2025
Company details

Annual accounts 2025

€93,827
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on ARTHUR PHARMA

ARTHUR PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61,718 and a net result of €58,718.

Its solvency ranks better than 77% of 25,428 sector peers (NACE 47) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ARTHUR PHARMA

What is the company number of ARTHUR PHARMA?
The company number of ARTHUR PHARMA is 1020.149.493. The VAT number is the same number with BE in front: BE 1020.149.493.
Where is ARTHUR PHARMA based?
The registered office is at Kleinenbergstraat 73, 1932 Zaventem.Company details
What does ARTHUR PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of ARTHUR PHARMA?
ARTHUR PHARMA is a private limited company (BV).
When was ARTHUR PHARMA founded?
ARTHUR PHARMA was founded on 19-02-2025.
Is ARTHUR PHARMA still active?
Yes, ARTHUR PHARMA is an active enterprise in the KBO register.
What is the turnover of ARTHUR PHARMA?
The turnover in financial year 2025 is about €380,000. This figure is estimated from the gross margin of €78,727 and 56 comparable companies (NACE 477). It probably lies between €200,000 and €560,000.Financials
Is ARTHUR PHARMA profitable?
In financial year 2025, ARTHUR PHARMA made a profit of €58,718.
Where can I find the annual accounts of ARTHUR PHARMA?
ARTHUR PHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of ARTHUR PHARMA due?
ARTHUR PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.